Premium
Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome: requirement for comprehensive complement analysis
Author(s) -
Wehling C.,
Kirschfink M.
Publication year - 2014
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/jth.12639
Subject(s) - eculizumab , atypical hemolytic uremic syndrome , medicine , shiga toxin , thrombotic microangiopathy , complement system , alternative complement pathway , immunology , hemolysis , diarrhea , regimen , intensive care medicine , disease , antibody , escherichia coli , biology , gene , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom